<DOC>
	<DOCNO>NCT02063425</DOCNO>
	<brief_summary>The objective study well characterize mechanisms action fluoxetine motor recovery specifically identify neurophysiological substrate underlie fluoxetine-induced motor recovery stroke . In study , investigator propose use transcranial magnetic stimulation ( TMS ) ass effect chronic treatment fluoxetine corticospinal excitability integrity .</brief_summary>
	<brief_title>`` Evaluation Transcranial Magnetic Stimulation Benefit Fluoxetine Motor Recovery After Stroke ''</brief_title>
	<detailed_description>Recently , phase IIb clinical trial ( Chollet et al. , 2011 - FLAME study ) reveal early administration standard-dose oral fluoxetine ( selective serotonin re-uptake inhibitor widely use antidepressant ) patient subacute ischaemic stroke moderate severe motor deficit upper extremity enhance motor recovery 3 month , assess Fugl-Meyer motor scale , suggest fluoxetine could promise drug promote recovery stroke patient . However , mechanism , specificity , fluoxetine improves motor function stroke remain poorly understood . The overall objective proposal well characterize mechanisms action fluoxetine motor recovery specifically identify neurophysiological substrate underlie fluoxetine-induced motor recovery stroke . The corticospinal system play key role voluntary activation upper limb muscle . Its integrity relate spontaneous ( incomplete ) recovery stroke . So far , effect fluoxetine corticospinal excitability integrity poorly explore although drug appear promising promote motor recovery . In study , investigator propose use transcranial magnetic stimulation ( TMS ) ass effect chronic treatment fluoxetine corticospinal excitability integrity . The investigator believe approach suitable determine mechanisms action drug motor recovery stroke . The investigator ass double-blind , monocentric ( Saint-Anne Hospital Stroke center ) , randomise , placebo-controlled study , effect chronic treatment fluoxetine corticospinal excitability integrity use TMS 40 patient suffer ischaemic stroke hemiplegia hemiparesis affect motor hand function . By couple TMS , visuomotor grip track task several clinical scale , investigator ' result allow system-specific assessment Fugl-Meyer motor scale fluoxetine-induced motor hand recovery stroke . We believe study support beneficial effect fluoxetine promote motor recovery stroke open new vista treatment option use fluoxetine patient motor impairment . It expect study provide preliminary data subsequently use design new , focused , clinical trial .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Man woman , age 18 80 year . Social security affiliation Inclusion day 3 day 15 stroke brain haemorrhage Hemiparesia upper limb motor deficit ( FuglMeyer score hand &lt; = 10 ) Informed consent Score NIHSS &gt; 20 Depression ( criterion DSM5R ) MADRS score &gt; 19 History recurrent bipolar depressive disorder . History behavior suicidal idea Family history extension interval QT congenital long interval QT History clinical stroke Aphasia prevent correct evaluation motor depression scale . Patients treat antidepressant drug , monoamine oxidase inhibitor ( IMAO ) , neuroleptic past month Benzodiazepines within 48 hour precede inclusion . Intolerance allergy fluoxetine ( SandozÂ® 20 mg pill ) Severe swallow disorder prevent oral administration treatment Planned carotid surgery Pregnant breastfeed woman Hepatic failure ( TGO TGP &gt; 2N ) ; severe renal failure ( creatinine &gt; 180micromol/l ) Concomitant severe disease allow followup . Participation another therapeutic study . Contraindication MRI TMS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Motor recovery</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Transcranial magnetic stimulation</keyword>
	<keyword>stroke</keyword>
</DOC>